切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - Peptidoglycan synthesis - interleukin receptor - CCR

11件产品中的 1-10

页面
每页
清除全部
  1. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  2. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  3. Cefoselis Sulfate
    B1906 Cefoselis Sulfate
    中文名: 硫酸头孢噻利
    Target: Peptidoglycan synthesis
    Summary: β-内酰胺抗生素
      ≥62.1 mg/mL
      ≥2.3 mg/mL
  4. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  5. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  6. Dexamethasone acetate
    B1926 Dexamethasone acetate
    中文名: 醋酸地塞米松
    Target: Glucocorticoid Receptors|interleukin receptor
    Summary: IL受体调节剂
      ≥13.35 mg/mL
      insoluble in H2O
  7. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  8. Maraviroc
    A8311 Maraviroc
     2 Citation
    中文名: 马拉维若
    Target: CCR
    Summary: CCR5选择性拮抗剂,抗逆转录病毒药物
      ≥25.7 mg/mL
      insoluble in H2O
  9. Dexamethasone (DHAP)
    A2324 Dexamethasone (DHAP)
    中文名: 地塞米松
    Target: interleukin receptor
    Summary: 糖皮质激素,抗炎活性
      ≥19.623 mg/mL
      insoluble in H2O
  10. INCB3344
    A3494 INCB3344
    Target: CCR
    Summary: CCR2趋化因子受体拮抗剂
      ≥25.9 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页